TAFASITAMAB-CXIX for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 429 adverse event reports in the FDA FAERS database where TAFASITAMAB-CXIX was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for TAFASITAMAB-CXIX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 218 | 29.6% | 41 | 8 |
| Lymphoma | 158 | 21.5% | 3 | 7 |
| Off label use | 126 | 17.1% | 7 | 20 |
| Death | 53 | 7.2% | 53 | 3 |
| Drug ineffective | 39 | 5.3% | 19 | 5 |
| Blood lactate dehydrogenase increased | 34 | 4.6% | 14 | 0 |
| Diffuse large b-cell lymphoma | 32 | 4.4% | 13 | 4 |
| Malignant neoplasm progression | 30 | 4.1% | 5 | 3 |
| Neutropenia | 30 | 4.1% | 5 | 7 |
| Polyneuropathy | 29 | 3.9% | 0 | 8 |
| Covid-19 | 28 | 3.8% | 9 | 17 |
| Cytopenia | 25 | 3.4% | 0 | 1 |
| Ill-defined disorder | 21 | 2.9% | 0 | 1 |
| Product use issue | 21 | 2.9% | 2 | 1 |
| Neoplasm progression | 20 | 2.7% | 7 | 0 |
Other Indications for TAFASITAMAB-CXIX
Product used for unknown indication (115)
Follicular lymphoma (58)
Diffuse large b-cell lymphoma refractory (31)
Lymphoma transformation (23)
Lymphoma (13)
Marginal zone lymphoma (13)
Diffuse large b-cell lymphoma recurrent (8)
Non-hodgkin's lymphoma (7)
B-cell lymphoma (5)
Marginal zone lymphoma refractory (5)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)